Model complex systems with precision and transparency

With Thales, you can engage stakeholders across your MIDD efforts—from translational scientists to regulatory reviewers—while equipping subject matter experts with the tools needed to model complex biology and pharmacology. 

With Thales, you get: 

  • Shareable project space for collaboration on modeling work 
  • Visualization tools that make model outputs accessible beyond modelers 
  • A high-level modeling language that supports engagement from pharmacologists and clinicians 
  • Transparent, traceable model structures suitable for internal and regulatory communication With Thales, you can: Inform clinical strategy by translating complex biological mechanisms into quantitative insight 
  • Produce calibrated, evidence-based simulations using any combination of published and proprietary data 
  • Identify dosing strategies and trial designs with a higher probability of success before entering the clinic 
  • Quantify uncertainty and parameter sensitivity to understand risk and strengthen decision confidence 

Turn mechanistic insight into clinical simulation

Thales is a powerful platform in which you can build models using your proprietary data, or choose to license validated models from our extensive QSP library.

  • What’s included
    • Standardized syntax for specifying reaction kinetics, state transitions, and differential equations 
    • Modular libraries for pathway modeling and reusable QSP components 
    • Virtual population generation and population-based simulation capabilities 
    • Automated parameter calibration and optimization tools 
    • Sensitivity and uncertainty analysis with parameter influence visualization 
    • Interactive plotting and analysis of model outputs 
    • Simulation pipelines that emulate clinical trial protocols 
    • Built-in documentation and version tracking for reproducibility 
    • Distributed compute execution for large-scale simulations 
  • License-ready models

    License-ready models built within Thales which provide a starting point for rapid exploration and can be adapted using proprietary data 

    • Dermatomyositis 
    • Inflammatory bowel disease (ulcerative colitis and Crohn’s disease) 

Resources